Center for Inflammatory Disease
Nashville, Tennessee, United States
Doctor in Nashville, Tennessee
2001 Charlotte Ave, Nashville, TN 37203
About Center for Inflammatory Disease
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
CSL Behring
1
Pfizer
1
Clinical Trials at Center for Inflammatory Disease
During the past decade, Center for Inflammatory Disease conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on
average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
2012-09-05
2016-10-12
Terminated
294
Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis
2012-06-01
2015-06-01
Completed
143
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
2014-03-14
2020-07-22
Completed
4,372
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
2015-01-26
2016-10-18
Completed
645
Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis
2016-01-22
2017-11-01
Completed
430
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Center for Inflammatory Disease
According to Clinical.Site data, the most researched conditions in "Center for Inflammatory Disease" are
"Arthritis, Rheumatoid" (4 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Center for Inflammatory Disease" in a lesser frequency.
Clinical Trials Intervention Types at Center for Inflammatory Disease
Most popular intervention types in "Center for Inflammatory Disease" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "BI 695501" (2 trials), "BI 695500" (1 trials), "Clazakizumab" (1 trials), "MabThera®" (1 trials) and "Placebo (Matching with Clazakizumab)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Center for Inflammatory Disease
The vast majority of trials in "Center for Inflammatory Disease" are
5 trials for "All" genders.
Clinical Trials Status at Center for Inflammatory Disease
Currently, there are NaN active trials in "Center for Inflammatory Disease".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Center for Inflammatory Disease,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Center for Inflammatory Disease, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".